Adynovate
1 known investors
The site presents ADYNOVATE, a PEGylated recombinant antihemophilic Factor VIII injectable used to treat and control bleeding in adults and children with hemophilia A. It provides prescribing and safety information for patients and healthcare providers.
BiotechHealthtech
Investors · 1
Frequently asked questions
- What does Adynovate do?
- The site presents ADYNOVATE, a PEGylated recombinant antihemophilic Factor VIII injectable used to treat and control bleeding in adults and children with hemophilia A. It provides prescribing and safety information for patients and healthcare providers.
- Who are Adynovate's investors?
- Adynovate's investors include HEALTHCARE ROYALTY PARTNERS.